
National Association of Testing Authorities, Australia
Scope of Accreditation
SA Pathology
Site
Women’s and Children’s Hospital Site
Accreditation No.
2494
Site No.
23963
Date of Accreditation
Contact
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Withdrawn
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2017
|
||
Service | Product | Determinant |
---|---|---|
Anatomical pathology - Tissue pathology - Non-coronial autopsy services | Body | Autopsy service and reporting |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Other body fluids; Sputum; Urine; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changes | Anus smears; Lip smears; Mouth smears; Nipple discharge; Nose smears; Skin smears | Cytological examination; Review and reporting of cytology samples |
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin fixed tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigationReporting only | Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue; Frozen tissueRenal and skin biopsies | Detection of antigenic targets - Various |
Anatomical pathology - Tissue pathology - Non-coronial autopsy servicesStatewide Perinatal Autopsy Service | Body; Body parts | Autopsy service and reporting |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Chemical pathology - Investigation of maternal markers to detect foetal abnormality | Serum | Oestriol - Unconjugated |
Free β-human chorionic gonadotropin (free β-hCG); Pregnancy associated plasma protein A (PAPP-A); α-Fetoprotein (AFP) |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Plasma; Serum | Ethanol; Gentamicin (cidomycin, septopal, genticyn, garamycin); Methotrexate; Paracetamol (acetaminophen); Tobramycin |
Serum | Vancomycin | |
Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | HDL - Quantitation |
Chemical pathology - Further investigation of renal and/or hepatic function | Serum | Bile acids - Quantitative |
Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Plasma | Ammonia; Lactate |
Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Bicarbonate; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | |
Plasma; Serum; Urine | Osmolality | |
Urine | Albumin; Calcium - Total; Chloride; Creatinine; Glucose; Potassium; Protein - Total; Sodium; Urate; Urea | |
Chemical pathology - Iron studies | Plasma; Serum | Ferritin; Iron; Transferrin |
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Calcium - Ionised; Chloride; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Chemical pathology - Tests for thyroid function | Plasma; Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free |
Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Cytogenetics - Detection of defined, balanced and/or unbalanced chromosomal abnormalities by in-situ hybridisation techniques | Amniotic fluid; Blood; Other body fluids; Tissues | Cytogenetic analysis and reporting |
Cytogenetics - Molecular karyotype (SNP microarray) detection of unbalanced chromosome abnormalities | Amniotic fluid; Blood; Other body fluids; Tissues | Cytogenetic analysis and reporting |
Cytogenetic analysis and reporting |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Chemical pathology - Biochemical genetic services for the diagnosis of metabolic and enzymological disorders | Tissues | Tissue culture and long term storage |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
Haematology - Examination of blood films by special staining | Blood | Malaria |
Heinz bodies | ||
Haematology - Foetal haemoglobin in maternal circulation | Blood | Detection and quantitation of foetal red cell antigens; Presence of foetal red blood cells |
Presence of anti-D | ||
Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices; Reticulocytes |
Differential number; Haemoglobin H (HbH) inclusions; Morphology; Reticulocytes | ||
Cerebrospinal fluid (CSF) | Differential number; Erythrocyte count (red blood cell count, RBCC) | |
Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Lupus anticoagulant |
Viscoelastic haemostatic testing (VHT) | ||
Anti-thrombin III; Factor II; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XI; Factor XII; Kaolin clotting time; Protein C and protein S; Von Willebrand factor (vWF) antigen - Quantitation | ||
International normalised ratio (INR) | ||
Activated partial thromboplastin time (APTT); D-dimer; Fibrinogen; Fibrinogen degradation products; Prothrombin time (PT) | ||
Platelet specific antibodies | ||
Platelet aggregation; Von Willebrand factor (vWF) activity - Ristocetin co-factor assay | ||
Haematology - Investigation of haemolysis | Blood | Hereditary spherocytosis |
Glucose phosphate isomerase (GPI) | ||
Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood; Bone marrow; Cerebrospinal fluid (CSF); Disaggregated tissues specimen; Serous fluid | CD10; CD103; CD117; CD11a; CD11b; CD11c; CD123; CD13; CD14; CD15; CD16; CD18; CD19; CD1a; CD2; CD20; CD21; CD22; CD23; CD24; CD25; CD27; CD28; CD3; CD30; CD33; CD34; CD36; CD4; CD40; CD41; CD42a; CD42b; CD42c; CD42d; CD43; CD44; CD45; CD49d; CD5; CD56; CD57; CD58; CD61; CD63; CD64; CD65; CD66c; CD7; CD79a; CD8; CD81; CD9; CD99; FMC7; GD2; HLA-DR antigen; Immunoglobulin M (IgM) specific for μ-chains; Kappa light chains; Lambda light chains; Myeloperoxidase; Neuron-glial antigen 2 (NG2); Terminal deoxynucleotidyl transferase (TdT) |
Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cells | Haemopoietic progenitor cells | Enumeration of CD34+ cells |
Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood; Cerebrospinal fluid (CSF); Disaggregated tissues specimen | CD16; CD19; CD2; CD20; CD3; CD4; CD56; CD8; HLA-DR antigen |
Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Anti-glutamic acid decarboxylase antibodies (GAD); Anti-islet cell antigen 2 antibodies |
Anti-islet cell antibodies (ICA) | ||
Immunopathology - Investigation and/or assessment of neutrophils - Functional tests | Blood | Qualitative assessment of neutrophils for the presence of oxidative pathway defects |
Serum | Quantitative assessment of oxidative pathways | |
Immunopathology - Investigation of natural killer cell release from target cells | Blood | Natural killer (NK) cell cytotoxicity; Natural killer (NK) cell number |
Immunopathology - Quantitation of complement proteins | Serum | Alternative pathway haemolytic complement; Total haemolytic complement |
Immunopathology - Quantitative and/or qualitative investigation of proteins | Cell culture medium; Serum | Cytokines |
Leucocytes (leukocytes) | Protein classes | |
Immunopathology - Quantitative investigation and/or assessment of neutrophils | Polymorphonuclear cells | Chemotaxis |
Bactericidal assay | ||
Quantitative iodination reaction | ||
Adherence | ||
Immunopathology - Tests of cellular immunity - Lymphocyte function tests | Blood | Lymphocyte function |
Proliferation by antigens; Proliferation by mitogens | ||
CD45RA; CD45RO; Lymphocyte quantitation |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Chemical pathology - Biochemical genetic services for the diagnosis of metabolic and enzymological disorders | Amniocytes; Blood; Chorionic villus; Plasma; Serum; Skin fibroblasts; Tissues | 7-Dehydrocholesterol; Very long chain fatty acids (vLCFA) |
Blood; Cerebrospinal fluid (CSF) | Pyruvate or other amino acids | |
Blood; Erythrocytes (red blood cells, RBC) | Plasmalogens | |
Blood; Plasma; Serum | Phytanic acid | |
Cerebrospinal fluid (CSF); Plasma; Urine | Amino acids | |
Plasma | Methylmalonic acid (MMA) | |
Glycosaminoglycans (MPS); Lysosomal profile | ||
18:0 Sulfatide | ||
Free fatty acids - Total | ||
Plasma; Urine | Carnitines; Creatine; Creatine and guanidinoacetate | |
Urine | Orotic acid | |
Trimethylamine | ||
Bile alcohols | ||
Mucopolysaccharides (MPS) | ||
Bile acid profile | ||
Sulfatide | ||
Organic acids | ||
Purines and pyrimidines; s-Sulfocysteine | ||
Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Chemical pathology - Dynamic tests | Sweat | Sweat tests |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Molecular genetics - Estimation of risk of inheritance of an unknown mutation (Bayesian and linkage calculations) | Amniotic fluid; Blood; Chorionic villus | Angelman syndrome; Fragile X; Maternal cell contamination; Myotonic dystrophy; Prader-Willi syndrome; Spinal muscular atrophy; Uniparental disomy |
Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes | Amniotic fluid; Blood; Chorionic villus | Angelman syndrome; Duchenne-Becker muscular dystrophy; Fragile X; Fragile XE mental retardation; Friedreich's ataxia (FRDA, FA); Incontinentia pigmenti; Kennedy's disease (spinal and bulbar muscular atrophy); Myotonic dystrophy; Prader-Willi syndrome; Spinal muscular atrophy; Spinocerebellar ataxia |
Amniotic fluid; Blood; Chorionic villus; Leucocytes (leukocytes); Skin fibroblasts | Canavan disease; Congenital disorder of glycosylation type 1a; Cystic fibrosis; D-bifunctional protein (DBP) deficiency; Fabry disease; Galactosemia; Gaucher disease; Glycogen storage disease type II (Pompe disease); Hexosaminidase A deficiency (Tay Sachs disease); Krabbe disease; Long chain 3-hydroxyacyl-coenzyme A dehydrogenase (LHCAD) deficiency; Medium chain acyl-coenzyme A dehydrogenase (MCAD); Metachromatic leukodystrophy (MLD, arylsulfatase A deficiency); Mucopolysaccharidosis diseases - MPS I, MPS II, MPS IIIA, IIIB, IVA, VI; Neuronal ceroid lipofuscinosis; Niemann-Pick disease type C; Rhizomelic chondrodysplasia punctata; Roche 1K disease; Smith-Lemli-Opitz syndrome; X-linked adrenoleukodystrophy; Zellweger | |
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted genes | Amniotic fluid; Blood; Chorionic villus | Angelman syndrome; Duchenne-Becker muscular dystrophy; Fragile X; Fragile XE mental retardation; Friedreich's ataxia (FRDA, FA); Incontinentia pigmenti; Kennedy's disease (spinal and bulbar muscular atrophy); Myotonic dystrophy; Prader-Willi syndrome; Spinal muscular atrophy; Spinocerebellar ataxia |
Blood; Leucocytes (leukocytes); Skin fibroblasts; Tissues | Canavan disease; Congenital disorder of glycosylation type 1a; Cystic fibrosis; D-bifunctional protein (DBP) deficiency; Fabry disease; Galactosemia; Gaucher disease; Glycogen storage disease type II (Pompe disease); Hexosaminidase A deficiency (Tay Sachs disease); Krabbe disease; Long chain 3-hydroxyacyl-coenzyme A dehydrogenase (LHCAD) deficiency; Medium chain acyl-coenzyme A dehydrogenase (MCAD); Metachromatic leukodystrophy (MLD, arylsulfatase A deficiency); Mucopolysaccharidosis diseases - MPS I, MPS II, MPS IIIA, IIIB, IVA, VI; Neuronal ceroid lipofuscinosis; Niemann-Pick disease type C; Rhizomelic chondrodysplasia punctata; Roche 1K disease; Smith-Lemli-Opitz syndrome; X-linked adrenoleukodystrophy; Zellweger | |
Molecular genetics - Prenatal genetic testing (excluding non-invasive prenatal [genetic] screening) | Amniotic fluid; Blood; Chorionic villus | Angelman syndrome; Duchenne-Becker muscular dystrophy; Fragile X; Fragile XE mental retardation; Friedreich's ataxia (FRDA, FA); Incontinentia pigmenti; Kennedy's disease (spinal and bulbar muscular atrophy); Myotonic dystrophy; Prader-Willi syndrome; Spinal muscular atrophy; Spinocerebellar ataxia |
Canavan disease; Classic infantile diseases - CLN1, CLN2, CLN3; Congenital disorder of glycosylation type 1a; Cystic fibrosis; D-bifunctional protein (DBP) deficiency; Fabry disease; Galactosemia; Gaucher disease; Glycogen storage disease type II (Pompe disease); Hexosaminidase A deficiency (Tay Sachs disease); Krabbe disease; Long chain 3-hydroxyacyl-coenzyme A dehydrogenase (LHCAD) deficiency; Medium chain acyl-coenzyme A dehydrogenase (MCAD); Metachromatic leukodystrophy (MLD, arylsulfatase A deficiency); Mucopolysaccharidosis diseases - MPS I, MPS II, MPS IIIA, IIIB, IVA, VI; Niemann-Pick disease; Rhizomelic chondrodysplasia punctata; Roche 1K disease; Smith-Lemli-Opitz syndrome; X-linked adrenoleukodystrophy; Zellweger | ||
Molecular genetics - Screening for an unknown mutation - Targeted genes | Blood | Familial Mediterranean fever; Prelingual deafness |
Molecular genetics/Cytogenetics - Bioinformatic analysis | DNA sequences; RNA sequences | Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Chemical pathology - Biochemical genetic services for the diagnosis of metabolic and enzymological disorders | Blood | Gal-1-p-uridyl transferase; Galactokinase; Galactose-1-phosphate |
Carnitine palmitoyl transferase I; Carnitine palmitoyl transferase II | ||
Liver | Glucose-6-phosphatase | |
Liver; Muscle | Phosphorylase - Total; Phosphorylase a; Phosphorylase b kinase | |
Urine | Oligosaccharides | |
Chemical pathology - Newborn screening services for the diagnosis of inborn errors of metabolism | Amniocytes; Blood; Chorionic villus; Leucocytes (leukocytes); Plasma; Skin fibroblasts | Arylsulfatase A |
Acid phosphatase; α-Fucosidase; α-Mannosidase; α-n-Acetylgalactosaminidase; β-Galactosidase; β-Glucuronidase; β-Hexosamindase - Total; β-Hexosamindase A (MUGS) | ||
Amniocytes; Blood; Chorionic villus; Leucocytes (leukocytes); Skin fibroblasts | Acid lipase; Sphingomyelinase; n-Acetylglucosamine-6-sulfatase; α-n-Acetylglucosaminidase; β-Galactocerebrosidase; β-Glucocerebrosidase | |
Galactose-6-sulfatase; Iduronate-2-sulfatase; Sulfamidase; α-Iduronidase | ||
n-Acetylgalactosamine-4-sulfatase | ||
Palmitoyl protein thioesterase; Sulfatase - Total; Tripeptidyl peptidase; α-Galactosidase A | ||
Phosphomannnoisomerase; Phosphomannomutase | ||
Amniocytes; Blood; Leucocytes (leukocytes); Skin fibroblasts | Dehydroepiandrosterone sulfate (DHEAS) sulfatase | |
Amniocytes; Chorionic villus; Dried blood spots; Muscle; Skin fibroblasts | α-Glucosidase | |
Amniocytes; Chorionic villus; Skin fibroblasts | Filipin staining for Niemann-Pick disease type C | |
Hypoxanthine/guanine phosphoribosyl transferase | ||
Catalase | ||
Ceremidase; Citrulline; Cystine; Debrancher enzyme; Dihydroacetonephosphate acyltransferase; Dihydroacetonephosphate alkyl synthase; Gal-1-p-uridyl transferase; Leucine decarboxylation; Neuraminidase; Phytanic acid oxidase | ||
Amniocytes; Chorionic villus; Skin fibroblasts; Urine | n-Acetylneuraminic acid (sialic acid, NANA) | |
Blood | Adenine phosphoribosyl transferase | |
Blood; Dried blood spots | α-Glucosidase; α-Iduronidase; β-Galactocerebrosidase; β-Glucocerebrosidase | |
Chitotriosidase; β-Galactosidase | ||
Blood; Leucocytes (leukocytes); Serum | n-Acetyl-β-glucosaminidase | |
β-Hexosaminidase - Heat inactivated | ||
Blood; Plasma; Serum | Chitotriosidase | |
Dried blood spots | α-Galactosidase A; α-Iduronidase | |
Liver | Carbamoyl-phosphate synthetase; Ornithine transcarbamylase |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Chemical pathology - Newborn screening services for the diagnosis of inborn errors of metabolism | Dried blood spots | Immunoreactive trypsin; Thyroid stimulating hormone (TSH) |
Gal-1-p-uridyl transferase; Galactose; Galactose-1-phosphate | ||
Methylmalonic acid (MMA) | ||
Acylcarnitine profile; Amino acids |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR) |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Microbiology - Bacteriology - Detection of pathogenic bacteria | Bacterial isolates | Bacteria; Pathogenic identification; Pathogenic microorganisms |
Antibiotic susceptibility; Bacteria; Pathogenic microorganisms | ||
Bacteria; Pathogenic identification; Pathogenic microorganisms | ||
Bacteria; Pathogenic identification; Pathogenic microorganisms | ||
Bacteria; Pathogenic microorganisms | ||
Bacteria; Pathogenic identification; Pathogenic microorganisms |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Immunohaematology - Blood group antibody detection | Blood; Plasma | Other blood group systems; Rh phenotypes |
Immunohaematology - Blood grouping | Blood | ABO; RhD |
Immunohaematology - Determination of compatibility of blood donor units | Blood | Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
Direct antiglobulin test (DAT, direct Coombs test) | ||
Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody elution |
Blood; Plasma | Other blood group antibodies; Red blood cell phenotyping; Rh | |
Plasma | Antibody titration | |
Immunohaematology - Investigation of blood transfusion reactions | Blood products | Antibodies |
Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2494
Site No.
23963
Print date
11 Dec 2023